相关实验视频
Updated: Jul 12, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
在诊断多系统性缩时,你有多么确定?
1From the Department for Personalized Genomic Medicine for Health and the Center for Personalized Medicine for Healthy Aging; and Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Japan.
Neurology
|October 19, 2023
概括
多重系统缩 (MSA) 是一种罕见的神经退行性疾病,影响30岁以上的成年人. 了解其独特的α-synuclein病理是准确诊断的关键,并将其与帕金森病区分开来.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
背景情况:
- 多重系统缩 (MSA) 是一种罕见的,致命的神经退行性疾病,影响30岁以上的成年人.
- 它呈现出帕金森症的特征,动脉缩和自主功能障碍.
- 在帕金森病 (PD) 之后,MSA是帕金森症的第二大常见原因.
研究的目的:
- 为了阐明MSA的病理生理学.
- 根据蛋白质聚合物来区分MSA和PD.
- 为了强调准确的MSA诊断的重要性,由于其异质的呈现.
主要方法:
- 审查目前对MSA病理生理学的理解.
- 在MSA和PD中对α-synuclein聚合物的比较.
- 临床病例分析突出诊断挑战.
主要成果:
- 在神经元和质细胞中,MSA的特征是独特的α-synuclein聚合物.
- 这些总量与帕金森病中观察到的不同.
- 异质的临床表现使诊断复杂化.
结论:
- 准确诊断MSA对于患者管理至关重要.
- 了解不同的病理学有助于差异诊断.
- 对MSA病原体的进一步研究是有必要的.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
924
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
924
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11

